Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2011

View Archived Issues

New tyrosine-protein kinase SYK inhibitors presented

New HIV-1 clade C consensus envelope sequence-based DNA vaccine is immunogenic in vivo

Novel imidazo[1,2-b]pyridazine derivative ameliorates symptoms of arthritis in vivo

New dipeptidyl peptidase 1 inhibitors claimed

Sanofi discloses novel pim inhibitors for cancer

Katholieke Universiteit Leuven describes new antifungal agents

Photocure begins enrollment in new phase II Visonac study

Merck & Co.'s new frizzled SMO receptor antagonist MK-5710 has antitumor activity in vivo

New MAP kinase-activated protein kinase 2 inhibitors discovered

PET tracer [18F]-MK-3328 shows favorable uptake in brain of patients with AD

Janssen Pharmaceuticals to divest U.S. Ortho Dermatologics division

FDA approves delayed-release mesalamine tablets for maintenance of remission of ulcerative colitis

COMP recommends orphan drug status for Nektar Therapeutics' lead oncology agent in ovarian cancer

Afexa Life Sciences clear to begin study of AFX-2 in patients with chronic lymphocytic leukemia

Cyclacel and Daiichi Sankyo amend sapacitabine licensing agreement

Daiichi Sankyo launches Lixiana in Japan

Nabi Biopharmaceuticals reports on first confirmatory phase III NicVAX study

Talon Therapeutics submits NDA for Marqibo to FDA

Dificid tablets launched in U.S. for CDI-associated diarrhea

Halaven launched in Japan for inoperable/recurrent breast cancer

Merck & Co. gains European approval for Victrelis

Japanese launch of Rivastach patch for Alzheimer's type-dementia

Chugai set to launch Mircera injection syringe in Japan for treatment of renal anemia

Phase III data presented on subcutaneous Actemra versus intravenous infusion

Upsher-Smith Laboratories initiates phase III trial of USL-261

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...